NEW YORK (GenomeWeb News) – Danaher today said it is extending its tender offer for Iris International to midnight EDT, Oct. 29 in order to allow investors time to consider new disclosures by Iris.

The tender offer previously was scheduled to expire at midnight EDT, Oct. 18. Danaher announced its plans to acquire Iris last month for $338 million.

In a document filed with the US Securities and Exchange Commission today, Iris disclosed new financial projections for 2012 to 2020.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.